Publications - Jeffrey L. Winters, M.D.

Back to research profile

  1. Winters JL, Burgstaler EA, Gottschall JL, Balogun RA, Houghton JR, Lee WJ, Snyder EL. A multicenter evaluation of a new therapeutic plasma exchange procedure. Transfusion. 2013 Apr 15. [Epub ahead of print]
    View PubMed
  2. Barbara DW, Mauermann WJ, Neal JR, Abel MD, Schaff HV, Winters JL. Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2013 Apr 13. [Epub ahead of print]
    View PubMed
  3. Winters JL. Randomized controlled trials in therapeutic apheresis. J Clin Apher. 2013 Feb; 28(1):48-55. Epub 2013 Jan 31.
    View PubMed
  4. Gandhi MJ, Carrick DM, Jenkins S, De Goey S, Ploeger NA, Wilson GA, Lee JH, Winters JL, Stubbs JR, Toy P, Norris PJ, National Heart, Lung, and Blood Institute (NHLBI) Specialized Center of Clinically Oriented Research (SCCOR) TRALI Study and Retrovirus Ep Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion. 2013 Jan 10. [Epub ahead of print]
    View PubMed
  5. Micallef IN, Sinha S, Gastineau DA, Wolf R, Inwards DJ, Gertz MA, Hayman SR, Hogan WJ, Johnston PB, Lacy MQ, Ansell SM, Buadi F, Dingli D, Dispenzieri A, Litzow MR, Porrata LF, Winters JL, Kumar S. Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization. Biol Blood Marrow Transplant. 2013 Jan; 19(1):87-93. Epub 2012 Aug 23.
    View PubMed
  6. Bentall A, Cornell LD, Gloor JM, Park WD, Gandhi MJ, Winters JL, Dean PG, Chedid MF, Stegall MD. Five-year allograft outcomes in living donor kidney transplants with anti-donor HLA antibody. Am J Transplant. 2013; 1:76-85.
  7. Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, Dezoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D, PEXIVAS Investigators. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials. 2013; 14:73. Epub 2013 Mar 14.
    View PubMed
  8. Jaben EA, Winters JL. Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature. J Clin Apher. 2012 Nov; 27(5):267-73. Epub 2012 Apr 24.
    View PubMed
  9. Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):845-53. Epub 2012 Oct 30.
    View PubMed
  10. Kreuter J, Winters JL. Drug-associated thrombotic microangiopathies. Semin Thromb Hemost. 2012 Nov; 38(8):839-44. Epub 2012 Oct 04.
    View PubMed
  11. Marshall CS, Andrzejewski C, Carey PM, Crookston KP, Li Y, Lopez-Plaza I, Sachais BS, Schwartz J, Winters JL, Wong EC, Wu Y. Milestones for Apheresis education. J Clin Apher. 2012 Nov; 27(5):242-6. Epub 2012 Jul 06.
    View PubMed
  12. Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS. A FACTOR FOUND IN THE IGG FRACTION OF SERUM OF PATIENTS WITH PARANEOPLASTIC BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION CAUSES PROLIFERATION OF CULTURED HUMAN MELANOCYTES. Retina. 2012 Oct; 32(9):1959-66.
    View PubMed
  13. Mateen FJ, Zubkov AY, Muralidharan R, Fugate JE, Rodriguez FJ, Winters JL, Petty GW. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol. 2012 Jun; 19(6):800-11. Epub 2012 Jan 04.
    View PubMed
  14. Kor DJ, Kashyap R, Weiskopf RB, Wilson GA, van Buskirk CM, Winters JL, Malinchoc M, Hubmayr RD, Gajic O. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med. 2012 Apr 15; 185(8):842-50. Epub 2012 Jan 26.
    View PubMed
  15. Winters JL. Low-density lipoprotein apheresis: principles and indications. Semin Dial. 2012 Mar-Apr; 25(2):145-51. Epub 2012 Jan 25.
    View PubMed
  16. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA, TRALI Study G Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757-67. Epub 2011 Nov 23.
    View PubMed
  17. Winters JL. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J Clin Apher. 2012; 27(6):312-9. Epub 2012 Jul 19.
    View PubMed
  18. Winters JL. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology Am Soc Hematol Educ Program. 2012; 2012:7-12.
    View PubMed
  19. Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher. 2011 Dec; 26(6):356-61. Epub 2011 Sep 5.
    View PubMed
  20. Sinha S, Gastineau D, Micallef I, Hogan W, Ansell S, Buadi F, Dingli D, Dispenzieri A, Gertz M, Greiner C, Hayman S, Inwards D, Johnston P, Lacy M, Litzow M, Porrata L, Winters JL, Kumar S. Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplant. 2011 Jul; 46(7):943-9. Epub 2010 Oct 11.
    View PubMed
  21. Hutchison CA, Cockwell P, Stringer S, Bradwell A, Cook M, Gertz MA, Dispenzieri A, Winters JL, Kumar S, Rajkumar SV, Kyle RA, Leung N. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol. 2011 Jun; 22(6):1129-36. Epub 2011 Apr 21.
    View PubMed
  22. Winters JL. Lipid apheresis, indications, and principles. J Clin Apher. 2011; 26(5):269-75. Epub 2011 Aug 10.
    View PubMed
  23. Winters JL. Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis. J Clin Apher. 2011; 26(5):239-42. Epub 2011 Aug 31.
    View PubMed
  24. Wootla B, Denic A, Keegan BM, Winters JL, Astapenko D, Warrington AE, Bieber AJ, Rodriguez M. Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int. 2011; 2011:780712. Epub 2011 Sep 22.
    View PubMed
  25. Burgstaler EA, Winters JL. Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus. J Clin Apher. 2011; 26(3):123-30. Epub 2011 Jan 25.
    View PubMed
  26. Winters JL, Brown D, Hazard E, Chainani A, Andrzejewski C Jr. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barre syndrome. BMC Health Serv Res. 2011; 11:101. Epub 2011 May 16.
    View PubMed
  27. Winters JL. Low Density Lipoprotein (LDL) Apheresis: Principles and Indications. Semin Dial. 2011.
  28. Jaben EA, Torloni AS, Pruthi RK, Winters JL. Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature. J Clin Apher. 2011; 26(4):219-24. Epub 2011 Apr 19.
    View PubMed
  29. Burgstaler EA, Winters JL. Comparison of hematopoietic progenitor cell collections using the COBE Spectra version 7 and Amicus version 3.1 for patients with AL amyloidosis. J Clin Apher. 2011; 26(4):186-94. Epub 2011 May 26.
    View PubMed
  30. Benidt GR, Jaben EA, Winters JL, Stubbs JR. Identification of anti-PP1P(k) in a blood donor and her family: a case report following her pregnancy and review. Transfus Apher Sci. 2010 Dec; 43(3):369-74. Epub 2010 Oct 27.
    View PubMed
  31. Elliott MA, Letendre L, Gastineau DA, Winters JL, Pruthi RK, Heit JA. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol. 2010 Jul; 85(1):43-50. Epub 2010 Mar 20.
    View PubMed
  32. Winters JL, Richa EM, Bryant SC, Tauscher CD, Bendix BJ, Stubbs JR. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions. Transfusion. 2010 Jul; 50(7):1444-52. Epub 2010 Mar 03.
    View PubMed
  33. Gloor JM, Winters JL, Cornell LD, Fix LA, DeGoey SR, Knauer RM, Cosio FG, Gandhi MJ, Kremers W, Stegall MD. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant. 2010 Mar; 10(3):582-9. Epub 2010 Jan 29.
    View PubMed
  34. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010; 25(3):83-177.
    View PubMed
  35. Burgstaler EA, Porrata LF, Markovic SN, Winters JL. Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor cell collection to increase lymphocyte yield and reduce cross-cellular contamination. J Clin Apher. 2010; 25(6):301-9. Epub 2010 Sep 07.
    View PubMed
  36. Nageswara Rao AA, Rodriguez V, Long ME, Winters JL, Nichols WL, Pruthi RK. Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodies. Pediatr Blood Cancer. 2009 Oct; 53(4):655-7.
    View PubMed
  37. Elliott MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol. 2009 Oct; 83(4):365-72. Epub 2009 Jun 08.
    View PubMed
  38. Jacob EK, Burgstaler EA, Winters JL, Stubbs JR, Gandhi MJ. Transfusion medicine illustrated. Thrombus formation during platelet donation. Transfusion. 2009 Oct; 49(10):2021.
    View PubMed
  39. Winters JL, Tran SA, Gastineau DA, Padley DJ, Dean PG, Kudva YC. Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programs. Am J Transplant. 2009 Jun; 9(6):1472-6. Epub 2009 May 13.
    View PubMed
  40. Gertz MA, Kumar SK, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Gastineau DA, Winters JL, Litzow MR. Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma. Bone Marrow Transplant. 2009 Apr; 43(8):619-25. Epub 2008 Nov 10.
    View PubMed
  41. Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, Rodriguez V. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion. 2009 Apr; 49(4):765-70. Epub 2008 Dec 15.
    View PubMed
  42. Li G, Daniels CE, Kojicic M, Krpata T, Wilson GA, Winters JL, Moore SB, Gajic O. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009 Jan; 49(1):13-20. Epub 2008 Oct 14.
    View PubMed
  43. Zakarija A, Kwaan HC, Moake JL, Banderanko N, Pandey DK, McKoy JM Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kid Int. 2009; 75:S20-S24.
  44. Rumilla KM, Winters JL, Peterman JM, Jedynak EA, Homburger HA. Development and validation of a fluorescent microsphere immunoassay for anti-IgA. Immunohematology. 2009; 25(1):24-8.
    View PubMed
  45. Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Litzow MR, Winters JL, Markovic SN. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant. 2008 Jul; 14(7):807-16.
    View PubMed
  46. Richa E, Krueger P, Burgstaler EA, Bryant SC, Winters JL. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion. 2008 Jul; 48(7):1325-32. Epub 2008 Mar 13.
    View PubMed
  47. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008 Jun; 73(11):1282-8. Epub 2008 Apr 02.
    View PubMed
  48. Burgstaler EA, Mako AM, Winters JL. Concentration changes to counteract the effects of bacteriological sampling on PLT yields. J Clin Apher. 2008; 23(2):74-81.
    View PubMed
  49. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med. 2007 Nov 1; 176(9):886-91. Epub 2007 Jul 12.
    View PubMed
  50. Shaz BH, Winters JL, Bandarenko N, Szczepiorkowski ZM. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication. Transfusion. 2007 Nov; 47(11):1963-71.
    View PubMed
  51. Gajic O, Yilmaz M, Iscimen R, Kor DJ, Winters JL, Moore SB, Afessa B. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med. 2007 Jul; 35(7):1645-8.
    View PubMed
  52. Fernandez Perez ER, Winters JL, Gajic O. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit. Am J Hematol. 2007 Jul; 82(7):631-3.
    View PubMed
  53. Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL. The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher. 2007 Jun; 22(3):96-105.
    View PubMed
  54. Shaz BH, Linenberger ML, Bandarenko N, Winters JL, Kim HC, Marques MB, Sarode R, Schwartz J, Weinstein R, Wirk A, Szczepiorkowski ZM. Category IV indications for therapeutic apheresis: ASFA fourth special issue. J Clin Apher. 2007 Jun; 22(3):176-80.
    View PubMed
  55. Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL, American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2007 Jun; 22(3):106-75.
    View PubMed
  56. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007 May; 131(5):1308-14.
    View PubMed
  57. Cooper LT, Belohlavek M, Korinek J, Yoshifuku S, Sengupta PP, Burgstaler EA, Winters JL. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy. J Clin Apher. 2007; 22(4):210-4.
    View PubMed
  58. Burgstaler EA, Cooper LT, Winters JL. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques. J Clin Apher. 2007; 22(4):224-32.
    View PubMed
  59. Dietz AB, Bulur PA, Emery RL, Winters JL, Epps DE, Zubair AC, Vuk-Pavlovic S. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion. 2006 Dec; 46(12):2083-9.
    View PubMed
  60. Rana R, Fernandez-Perez ER, Khan SA, Rana S, Winters JL, Lesnick TG, Moore SB, Gajic O. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006 Sep; 46(9):1478-83.
    View PubMed
  61. Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, DeGoey SR, Lager DJ, Grande JP, Stegall MD. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant. 2006 Aug; 6(8):1841-7. Epub 2006 Jun 19.
    View PubMed
  62. Winters JL. Complications of donor apheresis. J Clin Apher. 2006 Jul; 21(2):132-41.
    View PubMed
  63. Rana R, Afessa B, Keegan MT, Whalen FX Jr, Nuttall GA, Evenson LK, Peters SG, Winters JL, Hubmayr RD, Moore SB, Gajic O, Transfusion in the ICU Interest Group. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Crit Care Med. 2006 Jul; 34(7):1892-7.
    View PubMed
  64. Katipamula R, Porrata LF, Gastineau DA, Markovic SN, Moore SB, Greiner C, Burgstaler EA, Padley DJ, Winters JL. Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target. Bone Marrow Transplant. 2006 May; 37(9):811-7.
    View PubMed
  65. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant. 2006 Feb; 6(2):346-51.
    View PubMed
  66. Winters JL. Selective removal of plasma constituents: Current status and future possibilities. Blood Ther Med. 2006; 5:42-50.
  67. Pulido JS, Winters JL, Boyer D. Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results. Trans Am Ophthalmol Soc. 2006; 104:221-31.
    View PubMed
  68. Gloor JM, Lager DJ, Fidler ME, Grande JP, Moore SB, Winters JL, Kremers WK, Stegall MD. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation. 2005 Dec 15; 80(11):1572-7.
    View PubMed
  69. Pulido J, Sanders D, Winters JL, Klingel R. Clinical outcomes and mechanism of action for rheopheresis treatment of Age-Related Macular Degeneration (AMD). J Clin Apheresis. 2005 Oct; 20(3):185-94.
    View PubMed
  70. Katipamula R, Winters JL, Miller S, Moore SB. Bot Fly in a Blood Donor: Is it a Reason for Deferral? Transfusion. 2005; 45:1831.
    View PubMed
  71. Burgstaler EA, Winters JL, Pineda AA. Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis. Transfusion. 2004 Nov; 44(11):1612-20.
    View PubMed
  72. Winters JL, Moore SB, Sandness C, Miller DV. Transfusion of apheresis PLTs from IgA-deficient donors with anti-IgA is not associated with an increase in transfusion reactions. Transfusion. 2004 Mar; 44(3):382-5.
    View PubMed
  73. Winters JL, Gloor JM, Pineda AA, Stegall MD, Moore SB. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apheresis. 2004; 19(2):79-85.
    View PubMed
  74. Burgstaler EA, Pineda AA, Winters JL. Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator. J Clin Apheresis. 2004; 19(2):103-11.
    View PubMed
  75. Winters JL, Pineda AA. New directions in plasma exchange. Curr Opin Hematol. 2003 Nov; 10(6):424-8.
  76. Linz WJ, Tauscher C, Winters JL, Gastineau DA, Moore B. Transfusion medicine illustrated: cold agglutinin disease. Transfusion. 2003 Sep; 43(9):1185.
    View PubMed
  77. Fontaine MJ, Winters JL, Moore SB, McGregor CGA, Santrach PJ. Frozen preoperative autologous blood donation for heart transplantation at the Mayo Clinic from 1988 to 1999. Transfusion (Paris) 2003 Apr; 43(4):476-80.
    View PubMed
  78. Whayne TF, Zielke JC, Dickson LG, Winters JL. State of the art treatment of the most difficult low density lipoprotein (LDL) cholesterol problems: LDL apheresis. J Ky Med Assoc. 2002; 100:535-8.
    View PubMed
  79. Winters JL. Direct antiglobulin test (DAT) negative warm autoimmune hemolytic anemia. ASCP Transfusion Medicine Check Sample No. TM02-1(TM-253). Chicago, Ill: American Society of Clinical Pathologists. 2002.
  80. Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex 1 virus type specific serologic assays from MRL and Meridian Diagnostics. J Clin Microbiol. 2002; 40:1071-2.
    View PubMed
  81. Fleischman R, Letestu R, Mi X, Stevens D, Winters J, Debili N, Vainchenker W. Absence of mutations in HoxA10, HoxA11, and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome. Br J Haematol. 2002; 116:367-75.
    View PubMed
  82. Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton LJ 3rd, Vamvakas EC, Moore SB. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion. 2001 Nov; 41(11):1413-20.
    View PubMed
  83. Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics. J Clin Microbiol. 2001 Oct; 39(10):3740-2.
    View PubMed
  84. Winters JL, Wilson D, Davis DG. Congenital glioblastoma multiforme: a report of three cases and a review of the literature. J Neurol Sci. 2001 Jul 15; 188(1-2):13-9.
    View PubMed
  85. Winters JL, Pineda AA, McLeod BC, Grima KM. Therapeutic apheresis in renal and metabolic diseases. J Clin Apheresis. 2000; 15(1-2):53-73.
  86. Pineda AA, Vamvakas EC, Gorden LD, Winters JL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion. 1999 Oct; 39(10):1097-103.
  87. Winters JL, Gewirtz AS. Leukemoid reactions. ASCP Clinical Hematology Check Sample No. CH 99-4 (CH-38). Chicago, Ill: American Society of Clinical Pathologists. 1999.
  88. Winters JL, Gewirtz AS. Mature B-cell acute lymphoblastic leukemia in adults. ASCP Hematopathology Check Sample No. HP 98-5 (HP-31). Chicago, Ill: American Society of Clinical Pathologists; 1998.
  89. Winters JL, Jennings CD, Desai NS, Dickson LG, Ford RF. Neonatal alloimmune thrombocytopenia due to anti-HPA-1b (PLA2) (Zwb), a case report and review. Vox Sang. 1998; 74:256-9.
    View PubMed
  90. Winters JL, Gewirtz AS. Neonatal alloimmune thrombocytopenia. ASCP Transfusion Medicine Check Sample No. TM 97-5 (TM-217). Chicago, Ill: American Society of Clinical Pathologists; 1997.
  91. Winters JL, Chapman PH, Powell DE, Banks ER, Allen WR, Wood DP. Female pseudohermaphroditism due to congenital adrenal hyperplasia complicated by adenocarcinoma of the prostate and clear cell carcinoma of the endometrium. Am J Clin Path. 1996; 106:660-4.
    View PubMed
  92. Winters JL, Geil JD, O'Connor WN. Immunohistology, cytogenetics, and molecular studies of small round cell tumors of childhood: A review. Ann Clin Lab Sci. 1995; 25:66-78.
    View PubMed
  93. Winters JL, O'Connor WN, Broughton RA, Noonan JA. Bordetella bronchiseptica pneumonia in a patient with Down syndrome: A case report and review. Pediatrics. 1992; 89:1262-5.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.